ASXAZALOX MDS study advances to final Phase 1b cohort
other announcement
PXS
Pharmaxis
- Short interest
- 0.00%
- 0.00 pp 30d
- as of 12 July 2023
- Reported shorts
- 1
- Shares on issue
- 719.659M
Pharmaxis (PXS) News
Latest articles and price-sensitive announcements with AI sentiment classification.
Syntara to present at NWR Virtual Healthcare Conference
other announcement
SNT-4728 milestone payment received from Parkinsons UK
other announcement
Investor Presentation Euroz Hartleys Healthcare Forum
other announcement
Amsulostat and Garvan in MRFF funded pancreatic trial
other announcement
SNT-4728 Phase 2 iRBD Parkinsons UK Trial fully recruited
other announcement
Change of Director's Interest Notice - GP
director_dealing announcement
Change of Director's Interest Notice - KM
director_dealing announcement